Atlanta, GANCT05548244Now EnrollingIRB Ready

Depression Clinical Trial in Atlanta, GA

Access cutting-edge depression treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.

Sponsored by Emory University

Quick Self-Assessment

See if you qualify for this Atlanta location

Preparing your pre-screening questions…

Expert Care in Atlanta

Access depression specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related depression treatment provided free

Apply for This Atlanta Location

Check if you qualify for this depression clinical trial in Atlanta, GA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Atlanta

    Convenient for GA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Atlanta site if eligible
  4. 4Begin participation

About This Depression Study in Atlanta

The investigators will be comparing brain (neural) activation of depressed adolescent patients before, during and after a course of Behavioral Activation (BA) therapy using functional magnetic resonance imaging (fMRI). In particular, the project seeks to determine whether BA targets different neural mechanisms for behavioral avoidance associated with low motivation as compared to threat avoidance. A group of healthy controls will also be scanned as a comparator group for behavioral and imaging measures.

Sponsor: Emory University

Who Can Participate

Inclusion Criteria

Male and female adolescents ages 15-17;
current MDD diagnosis as determined by K-SADS-PL,
CDRS-R raw score \> 45 (T-score \> 65) at baseline;
estimated full scale IQ \> 80 as determined by the WASI-II;
able to receive outpatient care;
willing to not partake in other psychosocial treatments;
not taking psychotropic medications in the two weeks (four weeks for fluoxetine) prior to consent, with the exception of psychostimulant medication prescribed for the treatment of ADHD.
Additionally, depressed patients must have access to required technology (e.g. smart phone, tablet, or desktop computer) to complete the EMA portion of the study.
Healthy controls cannot not meet criteria for MDD and their CDRS-R raw score must be below 28; T-score \< 52).

Exclusion Criteria

Current or past diagnosis of bipolar, schizophrenia, schizophreniform, schizoaffective disorders, or psychosis NOS;
current diagnosis of developmental disorder, severe conduct disorder, life-threatening anorexia, OCD, or autism-spectrum disorders;
taking psychotropic medications prior to entry;
estimated IQ \< 80; alcohol/drug dependence or abuse within the last 3 months;
potential/confirmed neurological disorder or epilepsy;
claustrophobia;
presence of a medical condition that precludes fMRI;
endorsement of imminent and serious suicidality;
medical conditions that take precedence over the presence of MDD;
substance use (excluding nicotine) within two weeks of the fMRI scan;
left-handedness;
nicotine use within 3 hours of the fMRI scan;
history of traumatic brain injury or of being unconscious for more than 30 minutes;
a stimulant regime for ADHD which has changed within 30 days of the fMRI scan.
Non-compliance (i.e. \<70% completion) or inability (i.e. lack of smartphone device) to complete the 3 assessment periods of EMA.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Atlanta?

Yes, this clinical trial (NCT05548244) has an active research site in Atlanta, GA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Depression Treatment Options in Atlanta, GA

If you're searching for depression treatment options in Atlanta, GA, this clinical trial (NCT05548244) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced depression specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all depression clinical trials near you to find additional studies recruiting in your area.

More Depression Trials in Atlanta, GA

See all depression clinical trials recruiting in Atlanta — not just this study.

Browse Depression Trials in Atlanta →

Browse More Trials by Condition

Depression TrialsBipolar Disorder TrialsMajor Depressive Disorder TrialsAll Conditions →

Ready to Join in Atlanta?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Atlanta, GA